Breast Cancer Clinical Trial

Tamoxifen Pharmacogenetics and Clinical Effects

Summary

The purpose of this research is to try to identify which women who take tamoxifen are likely to suffer from hot flashes or are more likely to have other side effects or benefits from the drug. The researchers will do so by determining whether there are mutations that normally occur in human DNA that might influence the way individuals respond to medications.

View Full Description

Full Description

The study will test the following hypotheses.

There is a relationship between genetically distinct metabolic profiles of tamoxifen and the frequency and severity of hot flashes in women on chronic tamoxifen therapy.
Genetically distinct metabolic profiles for tamoxifen effect lipid profile, bone turnover metabolites and bone mineral density, and coagulation factors.
Different genetic profiles of estrogen responsive genes influence the pharmacodynamic effects of tamoxifen in cardiovascular system.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

18-years or older
Women with a prior breast cancer or who are at a high risk for developing the disease and about to start tamoxifen therapy.
Participants must not be treated with concomitant chemotherapy or hormone therapy other than tamoxifen. They must not have ovarian ablation or currently being treated with radiation therapy and/or chronic corticosteroids.
The participant must not be taking anti-hot flash therapy (clonidine, bellergal, megestrol acetate). Vitamin E, selective serotonin reuptake inhibitors, or herbal remedies are allowed provided that the participant has been taking the remedy for at least 4 weeks and intends to continue the remedy for at least the first month while on the study, and allows for one-month follow up evaluation (hot flash diaries and blood samples).
The participant must not be pregnant or lactating.
The participant is able and willing to sign an informed consent.

Study is for people with:

Breast Cancer

Estimated Enrollment:

297

Study ID:

NCT00228930

Recruitment Status:

Completed

Sponsor:

National Institute of General Medical Sciences (NIGMS)

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Indiana University
Indianapolis Indiana, 46202, United States
UMCCC
Ann Arbor Michigan, 48109, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

297

Study ID:

NCT00228930

Recruitment Status:

Completed

Sponsor:


National Institute of General Medical Sciences (NIGMS)

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider